Blue Cross Blue Shield of North Dakota (BCBSND) covers Norditropin as a preferred brand growth hormone for BCBSND Commercial members. As a result of the current Norditropin shortage, Genotropin was added to coverage as an additional preferred brand growth hormone option effective January 13, 2023. Norditropin remains covered as a preferred brand. For members with active Norditropin prior approvals (PAs), Genotropin PAs will automatically be added for the same duration of the Norditropin PA approval. If requesting PA for Genotropin, mention the Norditropin shortage to ensure it is taken into consideration during the review process.
*Note: This change does not apply to BCBSND Medicaid Expansion members.
Processing...
Please wait while your form is being submitted